Search

Search Constraints

You searched for: Author/Creator Kato, Naoya

Search Results

1. A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B class. (21st February 2018)

4. Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 10372 (21st January 2023)

5. Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial. Issue 11 (25th July 2022)

6. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. (July 2022)

7. Analysis of 307 cases with drug‐induced liver injury between 2010 and 2018 in Japan. Issue 1 (15th January 2019)

9. Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late‐onset hepatic failure in Japan. Issue 4 (5th March 2021)

10. Anti‐TNFα antibody versus non‐anti‐TNFα molecular agents for ulcerative colitis patients who failed initial anti‐TNFα therapy. Issue 6 (17th March 2022)